Somatostatin Receptor Theranostics for Refractory Meningiomas
Salgues, B.; Graillon, T.; Horowitz, T.; Chinot, O.; Padovani, L.; Taïeb, D.; Guedj, E. Somatostatin Receptor Theranostics for Refractory Meningiomas. Curr. Oncol. 2022, 29, 5550-5565. https://doi.org/10.3390/curroncol29080438
Salgues B, Graillon T, Horowitz T, Chinot O, Padovani L, Taïeb D, Guedj E. Somatostatin Receptor Theranostics for Refractory Meningiomas. Current Oncology. 2022; 29(8):5550-5565. https://doi.org/10.3390/curroncol29080438
Chicago/Turabian StyleSalgues, Betty, Thomas Graillon, Tatiana Horowitz, Olivier Chinot, Laetitia Padovani, David Taïeb, and Eric Guedj. 2022. "Somatostatin Receptor Theranostics for Refractory Meningiomas" Current Oncology 29, no. 8: 5550-5565. https://doi.org/10.3390/curroncol29080438